as one of their core products. Bookmark it. As soon as you see it disappear then we have something to worry about., but I doubt it. Mark my words, something is brewing.
Sentiment: Strong Buy
That is a great point. I checked the site and they still have Omontys listed despite all the negative media news. I agree this could very well indicate that not only they expect Omontys back in the market that they may be in negotiation for a buy-out from Affymax.
Peginesatide (For Anemia Due to Chronic Kidney Disease)
Peginesatide is an erythropoiesis-stimulating agent (ESA) for the treatment of anemia in adult patients on dialysis. It is the first ESA formulation in the U.S. to be approved for once monthly dosing.
In-house sales regions: U.S.
Brand Names: OMONTYS (U.S.)
New Product (Launched in April 2012)